Global Intellectual Property Specialists

Strategic global thinking for the pharmaceutical and biopharmaceutical industries

Our Capabilities

We use our global experience to support life sciences clients from early R&D to commercial launch, and beyond.

Explore our BioBlast®

View our interactive biosimilar news updates, collating tailored reports by brand, INN, originator/biosimilar applicant, litigation, region, or date.

Our People

Our lawyers and attorneys have science backgrounds, were trained at top tier firms, and most have experience in-house at multinational giants.

Award-winning IP services

Ranked internationally and domestically, our pharmaceutical, biopharmaceutical and life sciences focussed lawyers and attorneys are recognised as being among the best IP practitioners in the world.

Our Capabilities

Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys, to the pharmaceutical, biopharmaceutical and life sciences industries.

With staff based in Australia and New Zealand, we coordinate and execute local and multi-jurisdictional IP litigation strategies, provide IP/legal support for regional and global business development activities and licensing deals, and prosecute patent and trade mark applications around the world.

Patent: Legal and Attorney Services

Trade Mark: Legal and Attorney Services

Commercial IP Services

Regulatory Affairs Services

View our Capabilities

Since its establishment in 2017 boutique Pearce IP has dominated in the area of pharmaceutical patents. Thanks to its deep bench of talented professionals, any life sciences brief is dispatched with alacrity and poise.

IAM Patent 1000, 2024

IP SPECIALIST LAWYERS – PATENT ATTORNEYS – TRADE MARK ATTORNEYS

Our Leaders

Naomi Pearce

CEO, Executive Lawyer (AU, NZ), Patent & Trade Mark Attorney (AU, NZ)

Chris Coates (Maj Ret)

Executive, Finance

Helen Macpherson

Executive, Lawyer (Head of Litigation - Australia)

Kimberley Evans

Executive, Lawyer & Trade Mark Attorney (Head of Trade Marks - Australia)

Dr Mathew Lucas

Executive, Patent & Trade Mark Attorney

Paul Johns

Executive, Lawyer (Head of Litigation - New Zealand)

Julie Ballance

Executive, Patent Attorney and Trade Mark Practitioner (AU, NZ), Lawyer (NZ) & Notary (NZ)

Sally Paterson

Executive, Patent & Trade Mark Attorney (AU, NZ), Lawyer (NZ)

James Tocci

Executive, Corporate Services

Jacinta Flattery-O’Brien PhD

Special Counsel, Patent Attorney

Chantal Savage

Special Counsel, Lawyer

PEARCE IP BLOG

Read our latest updates & insights

When Public Disclosure Destroys Novelty But Possibly Not Confidentiality…

by Helen Macpherson, Kimberley Evans | Feb 11, 2026

This decision highlights the difference between disclosure under patent law and disclosure of confidential information and confirms that, just because an invention has been made “publicly available”, this does not mean that the invention has lost its confidential nature.

Pearce IP BioBlast® for the week ending 6 February 2026

by Naomi Pearce, Chantal Savage | Feb 10, 2026

Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 6 February 2026 are set out below…

A Double Blow for Moderna – Seqirus Topples Two mRNA Patent Applications

by Helen Macpherson, Naomi Pearce | Feb 9, 2026

Seqirus has successfully opposed Moderna’s: AU2015249553 patent application (AU553) for nucleic acid vaccines; and AU2017326423 (AU423) for high purity RNA compositions and methods for preparation of these compositions.